Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia
- PMID: 26050040
- PMCID: PMC4460187
- DOI: 10.1016/j.neuron.2015.04.022
Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia
Abstract
We sought to obtain novel insights into schizophrenia pathogenesis by exploiting the association between the disorder and chromosomal copy number (CNV) burden. We combined data from 5,745 cases and 10,675 controls with other published datasets containing genome-wide CNV data. In this much-enlarged sample of 11,355 cases and 16,416 controls, we show for the first time that case CNVs are enriched for genes involved in GABAergic neurotransmission. Consistent with non-genetic reports of GABAergic deficits in schizophrenia, our findings now show disrupted GABAergic signaling is of direct causal relevance, rather than a secondary effect or due to confounding. Additionally, we independently replicate and greatly extend previous findings of CNV enrichment among genes involved in glutamatergic signaling. Given the strong functional links between the major inhibitory GABAergic and excitatory glutamatergic systems, our findings converge on a broad, coherent set of pathogenic processes, providing firm foundations for studies aimed at dissecting disease mechanisms.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Bartos M., Vida I., Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 2007;8:45–56. - PubMed
-
- Battaglia A., Hoyme H.E., Dallapiccola B., Zackai E., Hudgins L., McDonald-McGinn D., Bahi-Buisson N., Romano C., Williams C.A., Brailey L.L. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics. 2008;121:404–410. - PubMed
Publication types
MeSH terms
Grants and funding
- P01 CA089392/CA/NCI NIH HHS/United States
- P50 DA019706/DA/NIDA NIH HHS/United States
- R01 EY020483/EY/NEI NIH HHS/United States
- 5R01CA133996/CA/NCI NIH HHS/United States
- 1 X01 HG005274-01/HG/NHGRI NIH HHS/United States
- MR/L010305/1/MRC_/Medical Research Council/United Kingdom
- P50 CA093459/CA/NCI NIH HHS/United States
- 5R01ES011740/ES/NIEHS NIH HHS/United States
- U01 HG004446/HG/NHGRI NIH HHS/United States
- G0801418/MRC_/Medical Research Council/United Kingdom
- R01 CA133996/CA/NCI NIH HHS/United States
- P50 CA097007/CA/NCI NIH HHS/United States
- 3P50CA093459/CA/NCI NIH HHS/United States
- 100202/WT_/Wellcome Trust/United Kingdom
- 5P50CA097007/CA/NCI NIH HHS/United States
- R01 ES011740/ES/NIEHS NIH HHS/United States
- G0800509/MRC_/Medical Research Council/United Kingdom
- HHSN268200782096C/HG/NHGRI NIH HHS/United States
- P50 CA084724/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
